Recursion Pharmaceuticals Inc is trading at $3.34 (+6.03%) following a strong opening session that aligns with a broad risk-on rally in U.S. equities.
- Major benchmarks including the S&P 500, Nasdaq, and Dow are all trading higher as market volatility eases.
- In the absence of company-specific news, the move appears driven by a broader bid for biotech and growth-oriented stocks.